New hope for Hard-to-Treat skin cancer: safer chemo combo enters trials
NCT ID NCT07535710
First seen Apr 23, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study tests a new combination of drugs (aclarubicin plus cyclophosphamide, vincristine, and prednisone, called CAOP) in 37 people aged 60+ with relapsed or refractory cutaneous T-cell lymphoma (CTCL), a rare skin cancer. The goal is to find the safest dose and see if it shrinks tumors, while avoiding heart damage common with standard chemo. Participants must have advanced disease (stage IIB–IV) and be in good overall health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEZARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ruijin Hospital Wuxi Branch
Wuxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.